Market Engagement Event for the provision of Isolators

NENC Provider Collaborative are looking to assess the feasibility of establishing an MHRA Specials licenced manufacturing facility capable of meeting Good Manufacturing Practice (GMP), quality and operational requirements to produce sterile medicines via aseptic manufacture.

The proposed output of this facility will be:

• 950,000 Ready to Administer (RtA) products
• 70,000 Systemic anti-cancer therapies and Monoclonal antibodies
• 70,000 Parenteral Nutrition products.
• 400,000 - 600,000 over labelled products.

In order to do this, we would like to understand the manufacturing equipment ( VHP Isolator Technologies ) available to produce the sterile medicines listed and how these will impact on the cleanroom design requirements.

It is intended to host a Market Engagement Event for providers of VHP Isolator Technologies on the 25th May 2023 to be held on site at:

North East and North Cumbria Manufacturing Facility, Northumbria Healthcare NHS manufacturing and innovation hub, Seaton Delaval, Northumberland.

Companies interested in attending the event must contact Kevin Marshall e-mail [email protected] to obtain an information pack.